M. Fisher

S. Rangarajan, C. Teo, R. Kulasegaram, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Are home sampling kits for sexually transmitted infections acceptable among men who have sex with men?

Helen E. Smith, C. Llewellyn, M. Fisher, 2009, Journal of health services research & policy.

Rising Population Cost for Treating People Living with HIV in the UK, 1997-2013

B. Gazzard, R. Brettle, M. Youle, 2010, PloS one.

Which aspects of health care are most valued by people living with HIV in high-income countries? A systematic review

C. Sabin, A. Miners, N. Perry, 2016, BMC Health Services Research.

Naively changing HAART

M. Youle, E. Beck, B. Gazzard, 2002, HIV medicine.

Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring.

B. Gazzard, C. Leen, A. Winston, 2013, The Journal of antimicrobial chemotherapy.

Neurologic and psychiatric safety profile of TMC278 compared with efavirenz in treatment-naïve, HIV-1-infected patients: pooled analysis from the randomized, double-blind, Phase III ECHO and THRIVE trials at 48 weeks

B. Clotet, A. Antinori, C. Hicks, 2011 .

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

B. Gazzard, D. Webster, C. Leen, 2013, The Journal of antimicrobial chemotherapy.

An Open-Label, Randomized Comparative Pilot Study of a Single-Class Quadruple Therapy Regimen versus a 2–Class Triple Therapy Regimen for Individuals Initiating Antiretroviral Therapy

Martin Fisher, Sundhiya Mandalia, B. Gazzard, 2006, Antiviral therapy.

Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies.

A. Owen, D. Back, Stephen Taylor, 2012, The Journal of antimicrobial chemotherapy.

Cessation of secondary prophylaxis in patients with cryptococcosis.

B. Gazzard, M. Fisher, N. Nwokolo, 2000, AIDS.

A Safety Study of Oral Valganciclovir Maintenance Treatment of Cytomegalovirus Retinitis

S. Walmsley, B. Kuppermann, F. Torriani, 2002 .

Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort

P. Kaleebu, D. Cooper, J. Weber, 2021, AIDS (London).

Data linkage reduces loss to follow-up in an observational HIV cohort study.

B. Gazzard, C. Leen, A. Winston, 2010, Journal of clinical epidemiology.

Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapy.

C. Leen, A. Winston, C. Sabin, 2015, The Journal of allergy and clinical immunology.

Preexposure prophylaxis for HIV infection: it's not as easy as ABC.

M. Fisher, 2007, Current opinion in infectious diseases.

Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002–2006: is this an outbreak?

A. Charlett, S. Bhagani, M. Johnson, 2007, Sexually Transmitted Infections.

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study

J. Nielsen, C. Leen, P. Vanhems, 2015, HIV medicine.

Consider acute hepatitis C, syphilis, and HIV in MSM with hepatitis

M. Fisher, D. Richardson, 2011, British medical journal.

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

D. Podzamczer, C. Katlama, H. Furrer, 2012, The Journal of antimicrobial chemotherapy.

Incoming HIV Virion-Derived Gag Spacer Peptide 2 (p1) is a Target of Effective CD8+ T Cell Antiviral Responses

C. Brander, V. Miller, T. Peto, 2020, SSRN Electronic Journal.

Factors influencing lopinavir and atazanavir plasma concentration.

B. Gazzard, C. Leen, D. Pillay, 2010, The Journal of antimicrobial chemotherapy.

Evidence for sexual transmission of HCV in recent epidemic in HIV-infected men in Southeast England.

Anne M Johnson, O. Pybus, C. Sabin, 2005 .

Management of syphilis in HIV-positive individuals.

F. Cresswell, M. Fisher, 2015, Sexual health.

HIV testing 2011 and beyond: can we make a difference?

E. Ong, A. Palfreeman, M. Fisher, 2011, International journal of STD & AIDS.

Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study

B. Gazzard, C. Sabin, P. Easterbrook, 2005, BMJ : British Medical Journal.

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)

C. Leen, A. Winston, C. Sabin, 2014, HIV medicine.

Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

C. Rietmeijer, F. Lampe, A. Rodger, 2015, HIV medicine.

Depression and virological status among UK HIV outpatients: results from a multicentre study

F. Lampe, A. Miners, S. Collins, 2012 .

CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF☆

C. Leen, M. Pirmohamed, L. Haddow, 2016, Cytokine.

Primary HIV infection masquerading as Munchausen’s syndrome

M. Fisher, D. Pao, D. McElborough, 2005, Sexually Transmitted Infections.

A case of a false positive result on a home HIV test kit obtained on the internet

M. Fisher, D. McElborough, 2005 .

Cystoid macular oedema in patients with AIDS and cytomegalovirus retinitis on highly active antiretroviral therapy

R. Newsom, M. Fisher, E. O'Moore, 1998, The British journal of ophthalmology.

The effect of HCV infection duration on HIV disease progression

D. Hawkins, C. Leen, A. Phillips, 2014 .

Treatment for hepatitis C infection in the UK Collaborative HIV Cohort (UK CHIC) study

C. Sabin, S. Bhagani, A. Rodger, 2015 .